Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post on LinkedIn:
“Great work with Caris Life Sciences, Hirva Mamdani, Dr. Balazs Halmos
Our work is the largest dataset published on the characteristics of BRAF-mutant non-small cell lung cancer!”
Title: Molecular and immune profiling of BRAF-mutated (BRAFMUT) non-small cell lung cancer (NSCLC)
Authors: Roupen Odabashian
Read the article here.
Other articles featuring Roupen Odabashian on OncoDaily.